Venetoclax
- PDF / 169,058 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 18 Downloads / 150 Views
1 S
Dizziness and diarrhea following an off-label use of venetoclax: 2 case reports In a retrospective study involving 12 patients who received an off-label therapy with venetoclax at the University of California Los Angeles from 2018–2019 to treat relapsed/refractory acute myeloid leukemia (AML), two patients [sexes and ages not sated] were described, who developed grade 3 dizziness (1 patient) and grade 3 diarrhoea (1 patient) following venetoclax an off-label therapy with venetoclax [routes and dosages not stated] for AML [durations of treatments to reactions onsets and outcomes not stated]. Gaut D, et al. Off-label use of venetoclax combination therapy in relapsed/refractory acute myeloid leukemia: A single institution experience. Blood 134 (Suppl. 1): 13 Nov 803446456 2019. Available from: URL: http://doi.org/10.1182/blood-2019-123071 [abstract]
0114-9954/20/1787-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 18 Jan 2020 No. 1787
Data Loading...
